PE-backed specialty pharma company Kelso Pharma appointed Giovanni Mauri as general manager of its recently acquired Italian ...

GSK's clinical-stage pipeline is currently focused on oncology, respiratory, immunology and inflammation, and infectious ...

Buoyed by new results from a phase 1b/2a trial, Roche has said it plans to start a phase 3 programme for an Alzheimer's ...

A proposal by the Biden administration to cover weight-loss medicines for obesity under Medicare has been axed by the White ...

Declining measles vaccination isn't a problem confined to the US. Last month, the World Health Organization (WHO) and UNICEF ...

Medical affairs is evolving. Once primarily viewed as a support function in healthcare, it now plays a central role in bridging the gap between research and clinical application. Today's medical ...

UK biotech Epsilogen has bought US-based TigaTx, pooling their resources to create what it says will be a leader in 'pan-isotope' cancer antibodies. Epsilogen rose to prominence a few years ago by ...

An experimental therapy for Parkinson's disease being developed by Roche and Prothena has missed the mark in a phase 2b trial, leaving them sifting through the data for signals of efficacy.